Role of mitogen-activated protein kinases in peptidoglycan-induced expression of inducible nitric oxide synthase and nitric oxide in mouse peritoneal macrophages: Extracellular signal-related kinase, a negative regulator

Clinical and Vaccine Immunology

Volumn 18, Issue 6, 2011, Pages 994-1001

  Bhatt, Kunal H ^a   Sodhi, Ajit ^a   Chakraborty, Rituparna ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PEPTIDOGLYCAN; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL CELL WALL; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; EX VIVO STUDY; FEMALE; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE SILENCING; GENE SYNTHESIS; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANIMALS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION; GRAM-POSITIVE BACTERIA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PEPTIDOGLYCAN; TRANSCRIPTION FACTOR AP-1;

EID: 79958009208     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00541-10     Document Type: Article

References (56)

1. Aga, M., et al. 2004. Evidence for nucleotide receptor modulation of cross talk between MAP kinase and NF-κB signaling pathways in murine RAW 264.7 macrophages. Am. J. Physiol. Cell Physiol. 286:C923-C930.
2. Auphan, N., J. A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286-289.
3. Barnes, P. J., and M. Karin. 1997. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066-1071.
4. Bennett, B. L., et al. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U. S. A. 98:13681-13686.
5. Bhatt, K. H., R. K. Pandey, Y. Dahiya, and A. Sodhi. 2010. Protein kinase Cδ and protein tyrosine kinase regulate peptidoglycan-induced nuclear factor- κB activation and inducible nitric oxide synthase expression in mouse peritoneal macrophages in vitro. Mol. Immunol. 47:861-870.
6. Boulton, T. G., et al. 1991. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65:663-675.
7. Brennan, F. M., and M. Feldmann. 1996. Cytokines in autoimmunity. Curr. Opin. Immunol. 8:872-877.
8. Carl, V. S., K. Brown-Steinke, M. J. Nicklin, and M. F. Smith, Jr. 2002. Toll-like receptor 2 and 4 (TLR2 and TLR4) agonists differentially regulate secretory interleukin-1 receptor antagonist gene expression in macrophages. J. Biol. Chem. 277:17448-17456.
9. Carter, A. B., and G. W. Hunninghake. 2000. A constitutive active MEK→ERK pathway negatively regulates NF-κB-dependent gene expression by modulating TATA-binding protein phosphorylation. J. Biol. Chem. 275:27858-27864.
10. Chan, E. D., and D. W. H. Riches. 1998. Potential role of the JNK/SAPK signal transduction pathway in the induction of iNOS by TNFα. Biochem. Biophys. Res. Commun. 253:790-796.
11. Chan, E. D., et al. 1999. Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFN-γ and TNFα in mouse macrophages. J. Immunol. 162:415-422. (Pubitemid 29018949)
12. Chen, C. C., P. C. Tsai, B. L. Wei, and W. F. Chiou. 2008. 8-Prenylkaempferol suppresses inducible nitric oxide synthase expression through interfering with JNK-mediated AP-1 pathway in murine macrophages. Eur. J. Pharmacol. 590:430-436.
13. Da Silva, J., B. Pierrat, J. L. Mary, and W. Lesslauer. 1997. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J. Biol. Chem. 272:28373-28380.
14. Davies, S. P., H. Reddy, M. Caivano, and P. Cohen. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95-105.
15. Derijard, B., et al. 1995. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267:682-685.
16. Diaz-Guerra, M. J., M. M. Velasco, P. Martin-Sanz, and L. Bosca. 1996. Evidence for common mechanisms in the transcriptional control of type II nitric oxide synthase in isolated hepatocytes: requirement of NF-κB activation after stimulation with bacterial cell wall products and phorbol esters. J. Biol. Chem. 271:30114-30120.
17. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2412.
18. Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. U. S. A. 92:7686-7689.
19. Dziarski, R., Y. P. Jin, and D. Gupta. 1996. Differential activation of extracellular signal-regulated kinase (ERK) 1, ERK2, p38, and c-Jun NH2 terminal kinase mitogen-activated protein kinases by bacterial peptidoglycan. J. Infect. Dis. 174:777-785.
20. Feng, G. J., et al. 1999. Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide- mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. J. Immunol. 163:6403-6412.
21. Frost, R. A., G. J. Nystrom, and H. C. Lang. 2004. Lipopolysaccharide stimulates nitric oxide synthase-2 expression in murine skeletal muscle and C2C12 myoblasts via Toll-like receptor-4 and c-Jun NH2-terminal kinase pathways. Am. J. Physiol. 287:C1605-C1615.
22. Guan, Z., S. Y. Buckman, L. D. Springer, and A. R. Morrison. 1999. Both p38α(MAPK) and JNK/SAPK pathways are important for induction of nitric- oxide synthase by interleukin-1β in rat glomerular mesangial cells. J. Biol. Chem. 273:12901-12908.
23. Gupta, D., T. N. Kirkland, S. Viriyakosol, and R. Dziarski. 1996. CD14 is a cell-activating receptor for bacterial peptidoglycan. J. Biol. Chem. 271: 23310-23316.
24. Gupta, D., Q. Wang, C. Vinson, and R. Dziarski. 1999. Bacterial peptidoglycan induces CD14-dependent activation of transcription factors CREB/ATF and AP-1. J. Biol. Chem. 274:14012-14020.
25. Ip, Y. T., and R. J. Davis. 1998. Signal transduction by the c-Jun N-terminal kinase (JNK): from inflammation to development. Curr. Opin. Cell Biol. 10:205-219.
26. Ishikawa, T., and P. L. Morris. 2006. Interleukin-1β signals through a c-Jun N-terminal kinase-dependent inducible nitric oxide synthase and nitric oxide production pathway in Sertoli epithelial cells. J. Androl. 147:5424-5430.
27. Jiang, C., A. T. Ting, and B. Seed. 1998. PPAR- agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86.
28. Laskin, D. L., and K. J. Pendino. 1995. Macrophages and inflammatory mediators in tissue injury. Annu. Rev. Pharmacol. Toxicol. 35:655-677.
29. Lin, A., et al. 1995. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 268:286-290.
30. -ΔΔCT method. Methods 25:402-408.
31. Lopez-Collazo, E., S. Hortelano, A. Rojas, and L. Bosca. 1998. Triggering of peritoneal macrophages with IFN-α/β attenuates the expression of inducible nitric oxide synthase through a decrease in NF-κB activation. J. Immunol. 160:2889-2895. (Pubitemid 28136744)
32. Lowenstein, C. J., et al. 1993. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon- and lipopolysaccharide. Proc. Natl. Acad. Sci. U. S. A. 90:9730-9734.
33. MacMicking, J., Q. W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-350.
34. Marks-Konczalik, J., S. C. Chu, and J. Moss. 1998. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor κB-binding sites. J. Biol. Chem. 273:22201-22208.
35. Martin, G. S., D. M. Mannino, S. Eaton, and M. Moss. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348:1546-1554.
36. Mizel, S. B. 1982. Interleukin 1 and T cell activation. Immunol. Rev. 63:51-72.
37. Moore, P. E., T. L. Church, D. D. Chism, R. A. Jr., Panettieri, and S. A. Shore. 2002. IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:L847-L853.
38. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051-3064.
39. Nathan, C. 1997. Inducible nitric oxide synthase: what difference does it make? J. Clin. Invest. 100:2417-2423.
40. ras. FEBS Lett. 408:33-38.
41. Rose, D. M., et al. 1997. Fcg receptor cross-linking activates p42, p38, and JNK/SAPK mitogen-activated protein kinases in murine macrophages. J. Immunol. 158:3433-3438.
42. Sanchez, I., et al. 1994. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 372:794-798.
43. Schwandner, R., R. Dziarski, H. Wesche, M. Rothe, and C. J. Kirschning. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274:17406-17409.
44. Sinke, A. P., et al. 2008. NF-κB in the mechanism of ammonia-induced astrocyte swelling in culture. J. Neurochem. 106:2302-2311.
45. Sodhi, A., and S. M. Singh. 1986. Release of cytolytic factor(s) by murine macrophages in vitro on treatment with cisplatin. Int. J. Immunopharmacol. 8:701-707.
46. Spink, J., J. Cohen, and T. J. Evans. 1995. The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase: activation by nuclear factor-κB. J. Biol. Chem. 270:29541-29547.
47. Uto, T., M. Fujii, and D. X. Hou. 2005. 6-(Methylsulfinyl)hexyl isothiocyanate suppresses inducible nitric oxide synthase expression through the inhibition of Janus kinase 2-mediated JNK pathway in lipopolysaccharide- activated murine macrophages. Biochem. Pharmacol. 70:1211-1221.
48. Wang, J. E., et al. 2000. Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infect. Immun. 68:3965-3970.
49. Wang, J. E., et al. 2004. Peptidoglycan of Staphylococcus aureus causes inflammation and organ injury in the rat. Crit. Care Med. 32:546-552.
50. Wang, Q., R. Dziarski, C. J. Kirschning, M. Muzio, and D. Gupta. 2001. Micrococci and peptidoglycan activate TLR2→MyD88→IRAK→TRAF→ NIK→IKK→NF-κB signal transduction pathway that induces transcription of interleukin-8. Infect. Immun. 69:2270-2276.
51. Wang, Z.-M., C. Liu, and R. Dziarski. 2000. Chemokines are the main pro-inflammatory mediators in human monocytes activated by Staphylococcus aureus, peptidoglycan, and endotoxin. J. Biol. Chem. 275:20260-20267.
52. Watters, J. J., et al. 2002. A differential role for the mitogen-activated protein kinases in lipopolysaccharide signaling: the MEK/ERK pathway is not essential for nitric oxide and interleukin 1β production. J. Biol. Chem. 277:9077-9087.
53. Xia, Z., M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
54. Xie, Q. W., R. Whisnant, and C. Nathan. 1993. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-γ and bacterial lipopolysaccharide. J. Exp. Med. 177:1779-1784.
55. Xie, Q. W., Y. Kashiwabar, and C. Nathan. 1994. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:4705-4708.
56. Yeh, P. Y., K. H. Yeh, S. E. Chuang, Y. C. Song, and A. L. Cheng. 2004. Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-κB activation by protein phosphatase 4-mediated NF-κB p65 Thr dephosphorylation. J. Biol. Chem. 279:26143-26148.